Common Stock and Stockholders' Equity (Deficit) - Additional Information (Details) - USD ($)
|
|
|
|
|
|
|
|
1 Months Ended |
3 Months Ended |
6 Months Ended |
|
|
Jun. 25, 2026 |
Mar. 03, 2026 |
Nov. 06, 2025 |
Dec. 20, 2024 |
Nov. 01, 2024 |
Feb. 05, 2024 |
Jan. 19, 2024 |
May 31, 2024 |
Aug. 31, 2023 |
Oct. 31, 2022 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Dec. 31, 2025 |
Feb. 28, 2025 |
| Temporary Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
500,000,000
|
|
|
500,000,000
|
|
500,000,000
|
|
| Preferred stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
10,000,000
|
|
|
10,000,000
|
|
10,000,000
|
|
| Common stock, shares issued |
|
|
|
|
|
|
|
|
|
|
30,736,401
|
|
|
30,736,401
|
|
15,437,410
|
|
| Proceeds from stock issued during period |
|
|
|
|
|
|
|
|
|
|
$ 31,000
|
|
$ 968,000
|
|
|
|
|
| Fair value of warrant liability |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ (6,700,000)
|
$ (1,777,000)
|
|
|
| Common stock par value |
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
$ 0.0001
|
|
$ 0.0001
|
|
| Warrant liability fair value |
|
|
|
|
|
|
|
|
|
|
$ 1,300,000
|
|
|
$ 1,300,000
|
|
|
|
| Expected term (years) |
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years 10 months 17 days
|
5 years 10 months 13 days
|
|
|
| Risk free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
3.56%
|
3.49%
|
|
|
| Expected volatility |
|
|
|
|
|
|
|
|
|
|
|
|
|
106.00%
|
101.00%
|
|
|
| Expected dividend yield |
|
|
|
|
|
|
|
|
|
|
|
|
|
0.00%
|
0.00%
|
|
|
| General and administrative |
|
|
|
|
|
|
|
|
|
|
$ 1,910,000
|
$ 2,569,000
|
|
$ 4,036,000
|
$ 4,842,000
|
|
|
| Preferred stock, par value |
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
$ 0.0001
|
|
$ 0.0001
|
|
| Conversion of stock description |
|
|
|
|
|
|
Each Placement Agent Warrant was accompanied by one Tranche A Common Warrant to purchase one half of a share of common stock and one Tranche B Warrant to purchase one half of a share of common stock, for an aggregate of 75,746 Common Warrants.
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from issuance Initial public offering |
|
|
|
|
$ 10,200,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| First Amendment to the Loan Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Temporary Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1
|
| 2024 Private Placement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Temporary Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants per share |
|
|
|
|
|
|
$ 0.0001
|
|
|
|
$ 3.827
|
|
|
$ 3.827
|
|
|
|
| Number of warrants converted to common stock |
|
|
|
|
|
7,839
|
67,908
|
|
|
|
|
|
|
|
|
|
|
| Gross proceeds from the private placement |
|
|
|
|
|
$ 20,400,000
|
|
|
|
|
|
|
|
|
|
|
|
| Net proceeds from issuance of private placement |
|
|
|
|
|
19,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Conversion of stock, shares converted |
|
|
|
|
|
|
75,746
|
|
|
|
|
|
|
|
|
|
|
| Sale of stock, shares |
|
|
|
|
|
|
4,985,610
|
|
|
|
|
|
|
|
|
|
|
| Commissions paid |
|
|
|
|
|
$ 1,400,000
|
|
|
|
|
|
|
|
|
|
|
|
| PIPE Financing |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Temporary Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock issued |
18,673,429
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from stock issued during period |
$ 15,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Public Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Temporary Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issued, price per share |
|
|
|
|
$ 3.75
|
|
|
|
|
|
|
|
|
|
|
|
|
| Underwriters option period |
|
|
|
|
30 days
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shelf Registration Statement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Temporary Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance and sale of equity |
|
$ 125,000,000
|
|
|
|
|
|
|
$ 100,000,000
|
|
|
|
|
|
|
|
|
| ATM |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Temporary Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from stock issued during period |
|
|
|
|
|
|
|
|
|
|
$ 30,000.00
|
|
|
$ 30,000.00
|
|
|
|
| Sale of stock, shares |
|
|
|
|
|
|
|
|
|
|
49,115
|
|
|
49,115
|
|
|
|
| Issuance and sale of equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 17,300,000
|
|
|
|
| Amended and Restated Certificate of Incorporation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Temporary Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
500,000,000
|
|
|
500,000,000
|
|
|
|
| Preferred stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
10,000,000
|
|
|
10,000,000
|
|
|
|
| Common stock par value |
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
$ 0.0001
|
|
|
|
| Preferred stock, par value |
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
$ 0.0001
|
|
|
|
| Chief Financial Officer |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Temporary Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock and warrants issued during period shares common stock and warrants |
|
|
|
|
|
|
|
10,000
|
|
|
|
|
|
|
|
|
|
| Warrant liability fair value |
|
|
|
|
|
|
|
$ 20,000
|
|
|
|
|
|
|
|
|
|
| Expected term (years) |
|
|
|
|
|
|
|
|
|
|
|
|
|
12 months
|
|
|
|
| Risk free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
4.42%
|
|
|
|
| Expected volatility |
|
|
|
|
|
|
|
|
|
|
|
|
|
89.00%
|
|
|
|
| Expected dividend yield |
|
|
|
|
|
|
|
|
|
|
|
|
|
0.00%
|
|
|
|
| General and administrative |
|
|
|
|
|
|
|
|
|
|
$ 0
|
2,000
|
|
$ 0
|
7,000
|
|
|
| Officers and Directors |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Temporary Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock and warrants issued during period shares common stock and warrants |
|
|
|
|
|
|
|
|
|
496,970
|
|
|
|
|
|
|
|
| Warrant liability fair value |
|
|
|
|
|
|
|
|
|
$ 125,000
|
|
|
|
|
|
|
|
| Expected term (years) |
|
|
|
|
|
|
|
|
|
10 years
|
|
|
|
|
|
|
|
| Risk free interest rate |
|
|
|
|
|
|
|
|
|
4.10%
|
|
|
|
|
|
|
|
| Expected volatility |
|
|
|
|
|
|
|
|
|
82.00%
|
|
|
|
|
|
|
|
| Expected dividend yield |
|
|
|
|
|
|
|
|
|
0.00%
|
|
|
|
|
|
|
|
| General and administrative |
|
|
|
|
|
|
|
|
|
|
$ 0
|
0
|
|
$ 0
|
1,000
|
|
|
| Warrant term |
|
|
|
|
|
|
|
|
|
10 years
|
|
|
|
|
|
|
|
| Directors, Employees or Consultants | 2024 Private Placement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Temporary Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants per share |
|
|
|
|
|
|
|
|
|
|
$ 4.3915
|
|
|
$ 4.3915
|
|
|
|
| Maximum | First Amendment to the Loan Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Temporary Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.32
|
| Maximum | Officers and Directors |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Temporary Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Vesting period |
|
|
|
|
|
|
|
|
|
48 months
|
|
|
|
|
|
|
|
| Minimum | First Amendment to the Loan Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Temporary Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1
|
| Minimum | Officers and Directors |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Temporary Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Vesting period |
|
|
|
|
|
|
|
|
|
12 months
|
|
|
|
|
|
|
|
| Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Temporary Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock issued |
|
|
|
|
|
|
|
|
|
|
49,115
|
|
490,073
|
2,080,943
|
|
|
|
| Proceeds from stock issued during period |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 5,800,000
|
|
|
|
| Fair value of common stock |
|
|
|
|
|
|
$ 8,500,000
|
|
|
|
|
|
|
|
|
|
|
| Common Stock | 2024 Private Placement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Temporary Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, shares issued |
14,938,370
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock | PIPE Financing |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Temporary Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issued, price per share |
$ 0.8033
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock | Public Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Temporary Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock issued |
|
|
|
|
2,720,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maximum number of additional shares issued |
|
|
|
|
408,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock | ATM |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Temporary Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of stock, shares |
|
|
9,700,000
|
4,450,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Remaining amount of available for offer and sale |
|
|
|
|
|
|
|
|
|
|
|
|
|
6,200,000
|
|
|
|
| Commissions paid |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 294,000
|
|
|
|
| Common Warrants | 2024 Private Placement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Temporary Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants per share |
|
|
|
|
|
|
|
|
|
|
$ 3.827
|
|
|
$ 3.827
|
|
|
|
| Pre Funded Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Temporary Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants per share |
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
$ 0.0001
|
|
|
|
| Warrant liability fair value |
|
|
|
|
|
|
|
|
|
|
$ 500,000
|
|
|
$ 500,000
|
|
|
|
| Pre Funded Warrants | 2024 Private Placement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Temporary Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants per share |
$ 0.0001
|
|
|
|
|
|
|
|
|
|
$ 3.8269
|
|
|
$ 3.8269
|
|
|
|
| Number of warrants converted to common stock |
|
|
|
|
|
|
306,506
|
|
|
|
|
|
|
|
|
|
|
| Decrease in warrant exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
0.0001
|
|
|
|
| Stock issued |
3,735,059
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pre Funded Warrants | PIPE Financing |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Temporary Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants per share |
$ 0.8032
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Placement Agent Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Temporary Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants per share |
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
$ 0.0001
|
|
|
|
| Warrant liability fair value |
|
|
|
|
|
|
|
|
|
|
$ 100,000
|
|
|
$ 100,000
|
|
|
|
| Tranche A Common Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Temporary Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants per share |
|
|
|
|
|
|
|
|
|
|
$ 5.36
|
|
|
$ 5.36
|
|
|
|
| Warrants expiration date |
|
|
|
|
|
|
|
|
|
|
Jul. 27, 2024
|
|
|
Jul. 27, 2024
|
|
|
|
| Warrant liability fair value |
|
|
|
|
|
|
|
|
|
|
$ 4,100,000
|
|
|
$ 4,100,000
|
|
|
|
| Expected term (years) |
|
|
|
|
|
|
|
|
|
|
|
|
|
11 months 8 days
|
|
|
|
| Risk free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
4.90%
|
|
|
|
| Expected volatility |
|
|
|
|
|
|
|
|
|
|
|
|
|
100.00%
|
|
|
|
| Expected dividend yield |
|
|
|
|
|
|
|
|
|
|
|
|
|
0.00%
|
|
|
|
| Fair value of warrants |
|
|
|
|
|
|
|
|
|
|
$ 0
|
|
|
$ 0
|
|
|
|
| Tranche A Common Warrants | 2024 Private Placement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Temporary Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants converted to common stock |
|
|
|
|
|
|
2,646,058
|
|
|
|
|
|
|
|
|
|
|
| Tranche B Common Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Temporary Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants per share |
|
|
|
|
|
|
|
|
|
|
$ 7.15
|
|
|
$ 7.15
|
|
|
|
| Fair value of warrant liability |
|
|
|
|
|
|
|
|
|
|
$ 0
|
200,000
|
|
$ 4,400,000
|
1,400,000
|
|
|
| Warrant liability fair value |
|
|
|
|
|
|
|
|
|
|
7,100,000
|
|
|
$ 7,100,000
|
|
|
|
| Expected term (years) |
|
|
|
|
|
|
|
|
|
|
|
|
|
1 year 8 months 8 days
|
|
|
|
| Risk free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
4.50%
|
|
|
|
| Expected volatility |
|
|
|
|
|
|
|
|
|
|
|
|
|
100.00%
|
|
|
|
| Expected dividend yield |
|
|
|
|
|
|
|
|
|
|
|
|
|
0.00%
|
|
|
|
| Fair value of warrants |
|
|
|
|
|
|
|
|
|
|
0
|
|
|
$ 0
|
|
|
|
| Tranche A and Tranche B Common Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Temporary Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of stock, shares |
|
|
|
|
|
|
2,646,058
|
|
|
|
|
|
|
|
|
|
|
| Warrants | First Amendment to the Loan Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Temporary Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants converted to common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,000,000
|
| Series A Warrants | 2024 Private Placement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Temporary Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants per share |
$ 0.8033
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock issued |
18,673,429
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Series B Warrants | 2024 Private Placement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Temporary Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants per share |
$ 1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock issued |
18,673,429
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tranche 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Temporary Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value of warrant liability |
|
|
|
|
|
|
|
|
|
|
1,100,000
|
$ 200,000
|
|
2,300,000
|
$ 400,000
|
|
|
| Warrant liability fair value |
|
|
|
|
|
|
|
|
|
|
$ 1,100,000
|
|
|
$ 1,100,000
|
|
|
|
| Expected term (years) |
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
| Risk free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
3.90%
|
|
|
|
| Expected volatility |
|
|
|
|
|
|
|
|
|
|
|
|
|
110.00%
|
|
|
|
| Expected dividend yield |
|
|
|
|
|
|
|
|
|
|
|
|
|
0.00%
|
|
|
|
| Tranche 1 | Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Temporary Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.32
|
| Number of warrants converted to common stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
641,163
|
| Warrants expiration date |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Feb. 28, 2030
|
| Post Merger Transaction | Officers and Directors |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Temporary Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants per share |
|
|
|
|
|
|
|
|
|
$ 10.42
|
|
|
|
|
|
|
|
| Number of warrants converted to common stock |
|
|
|
|
|
|
|
|
|
14,313
|
|
|
|
|
|
|
|